Who is Hanna M. Ollila?
Dr. Hanna M. Ollila is Group Leader of Ollila Lab at FIMM, University of Helsinki, where her team studies sleep genetics, narcolepsy, circadian rhythms, and brain autoimmunity.
Ollila Lab is a research group led by Dr. Hanna M. Ollila at FIMM, University of Helsinki. The lab studies sleep genetics, narcolepsy, circadian rhythms, brain autoimmunity, population genetics, bioinformatics, and post-infectious disease.
The group is based at the Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, and collaborates with Massachusetts General Hospital.
Dr. Hanna M. Ollila is Group Leader of Ollila Lab at FIMM, University of Helsinki, where her team studies sleep genetics, narcolepsy, circadian rhythms, and brain autoimmunity.
Ollila Lab investigates the genetic basis of sleep disorders and related immune and psychiatric conditions using population genetics, GWAS, bioinformatics, and collaborative cohort studies.
Ollila Lab is based at the Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, with research collaborations including Massachusetts General Hospital.
Researchers can contact the lab about collaborations, open positions, and data access through the contact page or by emailing hanna.m.ollila@helsinki.fi.
Ollila Lab researchers Hele Haapaniemi, Lea Urpa, Jesse Valliere, and Lovemore Kunorozva contributed to a landmark fibromyalgia study co-led by Hanna M. Ollila and published in Nature Medicine. The study identified 26 genetic risk loci and provides strong evidence for the condition's biological basis.